SEC Tracker
Get the app

Liminatus Pharma LIMN

Liminatus Pharma: signs a material agreement and sells unregistered shares

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Liminatus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Lexeo Therapeutics LXEO public float $217M, Jun 30, 2025
  2. Century Therapeutics IPSC public float $213M, Jun 30, 2025
  3. Monte Rosa Therapeutics GLUE public float $212M, Jun 30, 2025
  4. Tectonic Therapeutic TECX public float $232M, Jun 30, 2025
  5. Replimune Group REPL public float $235M, Sep 30, 2025